Timing of probiotic milk consumption during pregnancy and effects on the incidence of preeclampsia and preterm delivery: A prospective observational cohort study in Norway

BMJ Open

Volumn 8, Issue 1, 2018, Pages

  Nordqvist, Mahsa ^a   Jacobsson, Bo ^b,c   Brantsæter, Anne Lise ^c   Myhre, Ronny ^c   Nilsson, Staffan ^d   Sengpiel, Verena ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

MoBa.; Preeclampsia; preterm delivery; The Norwegian Mother and Child Cohort Study; timing of probiotic intake

Indexed keywords

PROBIOTIC AGENT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BACTERIUM CULTURE; BIFIDOBACTERIUM ANIMALIS; COHORT ANALYSIS; COMPARATIVE STUDY; CONSUMER; DIETARY SUPPLEMENT; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MEDICAL RECORD; MILK; NORWAY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL CARE; PROSPECTIVE STUDY; THIRD TRIMESTER PREGNANCY; ADOLESCENT; ANIMAL; BOVINE; GESTATIONAL AGE; MALE; MATERNAL EXPOSURE; NEWBORN; PREMATURITY; QUESTIONNAIRE; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; CATTLE; DIETARY SUPPLEMENTS; FEMALE; GESTATIONAL AGE; HUMANS; INCIDENCE; INFANT, NEWBORN; LOGISTIC MODELS; MALE; MATERNAL EXPOSURE; MILK; NORWAY; PRE-ECLAMPSIA; PREGNANCY; PREMATURE BIRTH; PROBIOTICS; PROSPECTIVE STUDIES; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; YOUNG ADULT;

EID: 85052177993     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2017-018021     Document Type: Article

References (73)

1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785-99.
2. Committee WE. The prevention of perinatal mortality and morbidity. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1970;457:1-60.
3. Morken NH, Vogel I, Kallen K, et al. Reference population for international comparisons and time trend surveillance of preterm delivery proportions in three countries. BMC Womens Health 2008;8:16.
4. Hamilton BE, Martin JA, Osterman MJ. Births: preliminary data for 2015. Hyattsville, MD: National Center for Health Statistics, 2016.
5. James JL, Whitley GS, Cartwright JE. Pre-eclampsia: fitting together the placental, immune and cardiovascular pieces. J Pathol 2010;221:363-78.
6. Goswami D, Tannetta DS, Magee LA, et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 2006;27:56-61.
7. von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy 2003;22:143-8.
8. Hu W, Wang H, Wang Z, et al. Elevated serum levels of interleukin-15 and interleukin-16 in preeclampsia. J Reprod Immunol 2007;73:166-71.
9. Mellembakken JR, Aukrust P, Hestdal K, et al. Chemokines and leukocyte activation in the fetal circulation during preeclampsia. Hypertension 2001;38:394-8.
10. Cudihy D, Lee RV. The pathophysiology of pre-eclampsia: current clinical concepts. J Obstet Gynaecol 2009;29:576-82.
11. McGregor JA, French JI, Richter R, et al. Antenatal microbiologic and maternal risk factors associated with prematurity. Am J Obstet Gynecol 1990;163(5 Pt 1):1465-73.
12. Menon R, Fortunato SJ. Infection and the role of inflammation in preterm premature rupture of the membranes. Best Pract Res Clin Obstet Gynaecol 2007;21:467-78.
13. Romero R, Espinoza J, Kusanovic JP, et al. The preterm parturition syndrome. BJOG 2006;113(Suppl 3):17-42.
14. Jacobsson B, Mattsby-Baltzer I, Andersch B, et al. Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women with preterm prelabor rupture of membranes. Acta Obstet Gynecol Scand 2003;82:423-31.
15. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000;342:1500-7.
16. Romero R, Espinoza J, Chaiworapongsa T, et al. Infection and prematurity and the role of preventive strategies. Semin Neonatol 2002;7:259-74.
17. Roberts JM. Preeclampsia: what we know and what we do not know. Semin Perinatol 2000;24:24-8.
18. Cindrova-Davies T. The therapeutic potential of antioxidants, ER chaperones, NO and H2S donors, and statins for treatment of preeclampsia. Front Pharmacol 2014;5:119.
19. Roberge S, Nicolaides K, Demers S, et al. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol 2017;216:110-20.
20. Roberge S, Demers S, Nicolaides KH, et al. Prevention of preeclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis. Ultrasound Obstet Gynecol 2016;47:548-53.
21. Lockwood CJ. Predicting premature delivery--no easy task. N Engl J Med 2002;346:282-4.
22. Fonseca EB, Celik E, Parra M, et al. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007;357:462-9.
23. Shapira N. Prenatal nutrition: a critical window of opportunity for mother and child. Womens Health 2008;4:639-56.
24. Englund-Ögge L, Brantsæter AL, Sengpiel V, et al. Maternal dietary patterns and preterm delivery: results from large prospective cohort study. BMJ 2014;348:g1446.
25. Haugen M, Brantsaeter AL, Trogstad L, et al. Vitamin D supplementation and reduced risk of preeclampsia in nulliparous women. Epidemiology 2009;20:720-6.
26. Brantsaeter AL, Haugen M, Samuelsen SO, et al. A dietary pattern characterized by high intake of vegetables, fruits, and vegetable oils is associated with reduced risk of preeclampsia in nulliparous pregnant Norwegian women. J Nutr 2009;139:1162-8.
27. Joint FAO/WHO working group report on drafting for the evaluation of probiotics in food. London, Ontario, Canada, 2002. http://www. who. int/ foodsafety/ fs- management/ en/ probiotic- guidelines. pdf
28. Reid G, Charbonneau D, Erb J, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 2003;35:131-4.
29. Reid G, Burton J, Hammond JA, et al. Nucleic acid-based diagnosis of bacterial vaginosis and improved management using probiotic lactobacilli. J Med Food 2004;7:223-8.
30. Yeganegi M, Watson CS, Martins A, et al. Effect of Lactobacillus rhamnosus GR-1 supernatant and fetal sex on lipopolysaccharideinduced cytokine and prostaglandin-regulating enzymes in human placental trophoblast cells: implications for treatment of bacterial vaginosis and prevention of preterm labor. Am J Obstet Gynecol 2009;200:532.e1-532.e8.
31. Bloise E, Torricelli M, Novembri R, et al. Heat-killed Lactobacillus rhamnosus GG modulates urocortin and cytokine release in primary trophoblast cells. Placenta 2010;31:867-72.
32. van Baarlen P, Troost F, van der Meer C, et al, 2011. Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proceedings of the National Academy of Sciences of the United States of America:4562-9.
33. Lorea Baroja M, Kirjavainen PV, Hekmat S, et al. Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clin Exp Immunol 2007;149:470-9.
34. Brantsaeter AL, Myhre R, Haugen M, et al. Intake of probiotic food and risk of preeclampsia in primiparous women: the Norwegian Mother and Child Cohort Study. Am J Epidemiol 2011;174:807-15.
35. Myhre R, Brantsæter AL, Myking S, et al. Intake of probiotic food and risk of spontaneous preterm delivery. Am J Clin Nutr 2011;93:151-7.
36. Magnus P, Irgens LM, Haug K, et al. Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa). Int J Epidemiol 2006;35:1146-50.
37. Magnus P, Birke C, Vejrup K, et al. Cohort Profile Update: The Norwegian Mother and Child Cohort Study (MoBa). Int J Epidemiol 2016;45:382-8.
38. Irgens LM. The Medical Birth Registry of Norway. Epidemiological research and surveillance throughout 30 years. Acta Obstet Gynecol Scand 2000;79:435-9.
39. Norwegian Institute of Public Health. Questionnaires from MoBa, Questionnaire 1. http://www. fhi. no/ dokumenter/ 1f32a49514. pdf
40. Norwegian Institute of Public Health. Questionnaires from MoBa, Questionnaire 3. http://www. fhi. no/ dokumenter/ 7b6b32b0cd. pdf
41. Haugen M, Brantsaeter AL, Alexander J, et al. Dietary supplements contribute substantially to the total nutrient intake in pregnant Norwegian women. Ann Nutr Metab 2008;52:272-80.
42. Norwegian Medical Association, The Norwegian Society of Obstetrics and Gynecology. Clinical guidelines in obstetrics (in Norwegian). 2014 http:/ /legef oreningen.no/ Fagmed/No rsk-gyneko logisk-fo re ning/Veileder e/Vei leder-i-fodse lshj elp- 2014 /Hyp erte nsivesvan gerskapskomplik asj oner- og- eklampsi/
43. Thomsen LC, Klungsøyr K, Roten LT, et al. Validity of the diagnosis of pre-eclampsia in the Medical Birth Registry of Norway. Acta Obstet Gynecol Scand 2013;92:943-50.
44. Palacios C, De-Regil LM, Lombardo LK, et al. Vitamin D supplementation during pregnancy: Updated meta-analysis on maternal outcomes. J Steroid Biochem Mol Biol 2016;164:148-55.
45. Kvalvik LG, Nilsen RM, Skjærven R, et al. Self-reported smoking status and plasma cotinine concentrations among pregnant women in the Norwegian Mother and Child Cohort Study. Pediatr Res 2012;72:101-7.
46. Watts DH, Krohn MA, Hillier SL, et al. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol 1992;79:351-7.
47. Andrews WW, Hauth JC, Goldenberg RL, et al. Amniotic fluid interleukin-6: correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery. Am J Obstet Gynecol 1995;173:606-12.
48. Freij BJ, South MA, Sever JL. Maternal rubella and the congenital rubella syndrome. Clin Perinatol 1988;15:247-57.
49. Vargesson N. Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res C Embryo Today 2015;105:140-56.
50. Sengpiel V, Bacelis J, Myhre R, et al. Folic acid supplementation, dietary folate intake during pregnancy and risk for spontaneous preterm delivery: a prospective observational cohort study. BMC Pregnancy Childbirth 2014;14:375.
51. Meltzer HM, Brantsaeter AL, Ydersbond TA, et al. Methodological challenges when monitoring the diet of pregnant women in a large study: experiences from the Norwegian Mother and Child Cohort Study (MoBa). Matern Child Nutr 2008;4:14-27.
52. Skreden M, Bere E, Sagedal LR, et al. Changes in fruit and vegetable consumption habits from pre-pregnancy to early pregnancy among Norwegian women. BMC Pregnancy Childbirth 2017;17:107.
53. Hillier SE, Olander EK. Women's dietary changes before and during pregnancy: A systematic review. Midwifery 2017;49:19-31.
54. Steinborn A, Schmitt E, Kisielewicz A, et al. Pregnancy-associated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs. Clin Exp Immunol 2012;167:84-98.
55. Tan M, Zhu JC, Du J, et al. Effects of probiotics on serum levels of Th1/Th2 cytokine and clinical outcomes in severe traumatic braininjured patients: a prospective randomized pilot study. Crit Care 2011;15:R290.
56. Polese B, Gridelet V, Araklioti E, et al. The Endocrine Milieu and CD4 T-Lymphocyte Polarization during Pregnancy. Front Endocrinol 2014;5:106.
57. Saito S, Nakashima A, Shima T, et al. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 2010;63:601-10.
58. Rautava S, Collado MC, Salminen S, et al. Probiotics modulate host-microbe interaction in the placenta and fetal gut: a randomized, double-blind, placebo-controlled trial. Neonatology 2012;102:178-84.
59. Aagaard K, Ma J, Antony KM, et al. The placenta harbors a unique microbiome. Sci Transl Med 2014;6:237ra65.
60. Jeffcoat MK, Hauth JC, Geurs NC, et al. Periodontal disease and preterm birth: results of a pilot intervention study. J Periodontol 2003;74:1214-8.
61. Offenbacher S, Lieff S, Boggess KA, et al. Maternal periodontitis and prematurity. Part I: Obstetric outcome of prematurity and growth restriction. Ann Periodontol 2001;6:164-74.
62. Ide M, Papapanou PN. Epidemiology of association between maternal periodontal disease and adverse pregnancy outcomes-- systematic review. J Clin Periodontol 2013;40(Suppl 14):S181-94.
63. Amarasekara R, Jayasekara RW, Senanayake H, et al. Microbiome of the placenta in pre-eclampsia supports the role of bacteria in the multifactorial cause of pre-eclampsia. J Obstet Gynaecol Res 2015;41:662-9.
64. Lye HS, Kuan CY, Ewe JA, et al. The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci 2009;10:3755-75.
65. Agerholm-Larsen L, Raben A, Haulrik N, et al. Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr 2000;54:288-97.
66. Aihara K, Kajimoto O, Hirata H, et al. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J Am Coll Nutr 2005;24:257-65.
67. Nilsen RM, Vollset SE, Gjessing HK, et al. Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatr Perinat Epidemiol 2009;23:597-608.
68. Nilsen SM, Krokstad S, Holmen TL, et al. Adolescents' healthrelated dietary patterns by parental socio-economic position, the Nord-Trøndelag Health Study (HUNT). Eur J Public Health 2010;20:299-305.
69. Brandhagen M, Lissner L, Brantsaeter AL, et al. Breast-feeding in relation to weight retention up to 36 months postpartum in the Norwegian Mother and Child Cohort Study: modification by socioeconomic status? Public Health Nutr 2014;17:1514-23.
70. Yang S, Li W, Challis JR, et al. Probiotic Lactobacillus rhamnosus GR-1 supernatant prevents lipopolysaccharide-induced preterm birth and reduces inflammation in pregnant CD-1 mice. Am J Obstet Gynecol 2014;211:44.e1-44.e12.
71. Daskalakis GJ, Karambelas AK. Vaginal Probiotic Administration in the Management of Preterm Premature Rupture of Membranes. Fetal Diagn Ther 2017;42.
72. Marteau P, Shanahan F. Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects. Best Pract Res Clin Gastroenterol 2003;17:725-40.
73. Vesa T, Pochart P, Marteau P. Pharmacokinetics of Lactobacillus plantarum NCIMB 8826, Lactobacillus fermentum KLD, and Lactococcus lactis MG 1363 in the human gastrointestinal tract. Aliment Pharmacol Ther 2000;14:823-8.